Fragrance direction affects more than the scent of a body lotion. It can influence formula work, sample comparisons, ingredient information, artwork and the way a lotion connects to a body wash, oil or mist. An unscented or fragrance-free direction also needs careful definition because the terms may be understood or regulated differently by market and product context.
Begin by deciding what commercial role scent plays. Is fragrance the main identity of the product, a quiet background, an optional variant or intentionally absent as an added perfume direction? Record the intended product use and destination market before asking the fragrance supplier or factory for supporting information.
Define the fragrance route in plain project language
Avoid relying on one public-facing term at the development stage. State whether the brief allows an added fragrance mixture, uses naturally aromatic materials, seeks no added perfume or intends another clearly described route. List ingredient constraints and the reason they matter to the concept.
Ask the supplier to confirm how it interprets the request and which materials contribute odour. A product can have a noticeable base odour without an added fragrance mixture, while a low-fragrance concept still uses fragrance. Final wording should follow the actual formula and current destination-market review.
Describe scent character and intensity
Provide fragrance family, mood, reference cues and intensity direction without asking for an exact copy. Explain whether the lotion should match another SKU or simply belong to the same range. If a physical fragrance or product reference is supplied, identify the characteristic being studied.
Separate scent preference from lotion texture and appearance. During sample review, code fragrance options and keep the base consistent where possible. Record intensity during application and the residual impression at a stated later point.
Review intended use under the IFRA framework
IFRA Standards are a fragrance-industry risk-management system and apply according to intended product application categories. IFRA explains that its Standards can prohibit, restrict or set specifications for certain fragrance materials and that companies must also comply with applicable laws. The Standards do not replace a finished-product safety assessment or local regulation.
Ask for fragrance information that corresponds to the intended body lotion use. A supplier document for another application should not be assumed to cover a leave-on product. Confirm the fragrance reference, document revision and any concentration or category information needed by the responsible technical team.
Discuss destination-market allergen labelling
The European Union fragrance-allergen amendment updates individual labelling requirements and distinguishes concentration thresholds for leave-on and rinse-off products. Other markets have their own rules and timelines. Provide the intended markets early so the relevant ingredient and artwork questions can be raised before printing.
Do not present an IFRA conformity document as proof of universal compliance or as certification issued by IFRA for the finished lotion. The brand or responsible party should review the actual formula, ingredient list and current market duties.
Keep terminology tied to the final formula
Terms such as unscented, fragrance-free, perfume-free or no added fragrance should not be treated as interchangeable without market review. The formula may contain materials with odour or multifunctional ingredients, and the destination market may have expectations for how the public wording is substantiated.
Choose public language only after the final formula and ingredient information are available. If the formulation changes, reassess the term and any related artwork. Avoid implying that the absence of added fragrance guarantees that no consumer can experience sensitivity.
Review fragrance in the packaging and use context
The product-contact pack, headspace, dispensing amount and storage conditions can affect the user's scent experience. Review the lotion through the intended dispenser and with the expected dose. For a matching range, evaluate wash, lotion, oil and mist separately because rinse-off and leave-on uses are not identical.
Record whether component material, colour or decoration is provisional. A fragrance approval in a lab jar does not approve the final pack, and a packaging change should be connected to the relevant compatibility and sensory review.
Consolidate sample approval
Use coded samples and score fragrance character, intensity during application, balance with the base and residual impression separately. Name one person to consolidate comments. If the formula base also changes, note that the comparison cannot isolate fragrance alone.
The approval record should identify fragrance reference, formula revision, sample code, pack used and open documentation or market questions. This keeps a preferred scent from being confused with complete product approval.
Use an early fragrance-planning checklist
- Added fragrance, no-added-perfume or other defined project route
- Intended user, use occasion and product application category
- Fragrance family, mood, intensity and acceptable variation
- Matching or coordinated products in the range
- Destination markets and artwork languages
- Ingredient or public-wording questions requiring review
- Fragrance supplier reference and current document revision
- Intended-use information under the applicable IFRA category
- Formula, pack and dose used for sample review
- Consolidated scent approver and approval record
- Change trigger for fragrance, formula, component or market
Keep commercial and technical decisions connected
A fragranced range can add fragrance variants, artwork versions and separate sample approvals. A no-added-fragrance direction can create its own formula and public-wording questions. Ask the quotation and timeline to state the assumed route rather than treating fragrance as a decoration added at the end.
King Metis can discuss fragrance direction as part of a defined body lotion and body care brief. Final formula, supplier information, labelling and market responsibilities remain specific to the approved product.